GlassScriptPhysician profile
Michael Gwartney
NPI 1619995248
$2,747.46
in general payments reported to CMS, 2019-2025
16 companies · $644 in 2025
The $644 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.39 · 2020: $60.14 · 2021: $217 · 2022: $346 · 2023: $699 · 2024: $695 · 2025: $644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,980 · Education: $57.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,980.38 |
| Education | $57.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $968.02 | 2023-2025 | Inspire |
| Genzyme Corporation | $438.51 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $385.28 | 2022-2025 | Dupixent |
| Glaxosmithkline, LLC. | $199.84 | 2022-2025 | Nucala |
| Intersect Ent, INC. | $179.23 | 2019-2021 | |
| Kaleo, INC. | $129.97 | 2019-2023 | Auvi-Q |
| Stryker Corporation | $103.51 | 2019-2022 | |
| Alk-Abello, INC | $92.41 | 2022-2023 | Grastek, Ragwitek, Odactra |
| Ars Pharmaceuticals Operations, INC. | $51.30 | 2025 | Neffy |
| Merck Sharp & Dohme LLC | $36.01 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $34.99 | 2021 | |
| Aerin Medical INC. | $31.28 | 2021 | |
| Neurent Medical Limited | $27.90 | 2024 | Neuromark Radiofrequency Console, Neuromark Device |
| Acclarent, INC | $24.80 | 2022 | |
| Paratek Pharmaceuticals, INC. | $22.38 | 2025 | Nuzyra, Xhance |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $22.03 | 2024 | Coolseal Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gwartney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.